Brief: Alembic Pharmaceuticals Receives USFDA Tentative Approval For Bosutinib Tablets, 400 Mg
12/01/2026 06:39
Jan 12 (Reuters) - Alembic Pharmaceuticals Ltd ALEM.NS: RECEIVES USFDA TENTATIVE APPROVAL FOR BOSUTINIB TABLETS, 400 MG Source text: ID:nBSEVfNtG Further company coverage: ALEM.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand